anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 08.12.17 | Roche Neutral | UBS AG | |
| 08.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.17 | Roche Neutral | UBS AG | |
| 07.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.12.17 | Roche Neutral | UBS AG | |
| 06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novartis Underperform | Merrill Lynch & Co., Inc. | |
| 01.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 01.12.17 | Novartis overweight | Morgan Stanley | |
| 01.12.17 | Roche Outperform | Bernstein Research | |
| 21.11.17 | Roche buy | Baader Bank | |
| 21.11.17 | Roche Hold | Deutsche Bank AG | |
| 21.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.17 | Roche Reduce | HSBC | |
| 20.11.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 17.11.17 | Roche Equal-Weight | Morgan Stanley | |
| 17.11.17 | Roche Hold | Deutsche Bank AG | |
| 17.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 16.11.17 | Roche buy | Jefferies & Company Inc. | |
| 14.11.17 | Novartis overweight | Morgan Stanley | |
| 08.11.17 | Novartis Hold | Deutsche Bank AG | |
| 06.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 02.11.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | Roche overweight | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.17 | Novartis buy | HSBC | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.10.17 | Novartis buy | Baader Bank | |
| 30.10.17 | Novartis Neutral | UBS AG | |
| 30.10.17 | Novartis buy | HSBC | |
| 30.10.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.10.17 | Novartis Outperform | Bernstein Research | |
| 25.10.17 | Novartis Underweight | Barclays Capital | |
| 25.10.17 | Novartis Neutral | JP Morgan Chase & Co. |